Timely patient access to medication has become an acute problem in the UK healthcare system, with patients often caught in a tug-of-war between an overburdened NHS and the high costs of tra
Pharmaceutical companies face increasing pressure to demonstrate not only the efficacy of their treatments, but also the impact of these treatments on patients' lives.
In his recent speech on the need for NHS reform, the prime minister announced that support for preventative care in communities would be at the heart of the Government’s approach.
From consumer products to clinical trials, anything that is designed without input from its intended recipients will likely feel disconnected from their needs.
For over 30 years, the US has clung to an outdated and misguided war on testosterone, lumping it in with the anabolic steroids that come under the 1990 Anabolic Steroid Control Act.
Join the conversation, on Tuesday 28th January @ 10 am ET - 3 pm GMT - 4 pm CET, in our webinar sponsored by Syneos Health, entitled ‘Health Trends 2025: Reimagining What's Possibl
